These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. U.S. Food and Drug Administration requirements for toxicity testing of contraceptive products. Berliner VR. Acta Endocrinol Suppl (Copenh); 1974; 185():240-65. PubMed ID: 4206185 [No Abstract] [Full Text] [Related]
13. [Ovulation inhibition with low dosage gestagen components. Results of international clinical trial of Orlest]. Figoureux J, Onghena G, Schlikker E, Wattiez M, Schlösser W, Vercautere E, William P. Munch Med Wochenschr; 1967 Dec 01; 109(48):2555-8. PubMed ID: 5631905 [No Abstract] [Full Text] [Related]
14. Amenorrhea following use of oral contraceptives. Rifkin I, Nachtigall LE, Beckman EM. Am J Obstet Gynecol; 1972 Jun 01; 113(3):420-32. PubMed ID: 4678381 [No Abstract] [Full Text] [Related]